Innate anti-tumor immunity is primarily performed by natural killer (NK) (CD3−CD56+) and NK/T (CD3+CD56+) as well as soluble factors abundant in the tumor microenvironment [15]. This evidence concerns the gene NCAM1 and neoplasm.